Steris Corp. Declares Quarterly Dividend of $0.28 (ste)
Steris Corp. (NYSE:ste) announced a quarterly dividend on Wednesday, November 2nd. Shareholders of record on Wednesday, November 23rd will be given a dividend of 0.28 per share on Wednesday, December 21st. This represents a $1.12 annualized dividend and a yield of 1.67%. The ex-dividend date of this dividend is Monday, November 21st.
Shares of Steris Corp. (NYSE:STE) opened at 66.91 on Wednesday. The firm’s 50-day moving average price is $69.17 and its 200 day moving average price is $69.81. The company has a market capitalization of $5.70 billion, a PE ratio of 33.78 and a beta of 1.30. Steris Corp. has a 1-year low of $61.38 and a 1-year high of $78.77.
Steris Corp. (NYSE:STE) last posted its quarterly earnings results on Wednesday, November 2nd. The company reported $0.89 EPS for the quarter, missing analysts’ consensus estimates of $0.90 by $0.01. The company earned $646.40 million during the quarter, compared to the consensus estimate of $670.24 million. Steris Corp. had a return on equity of 9.89% and a net margin of 6.41%. The company’s revenue for the quarter was up 31.9% compared to the same quarter last year. During the same period last year, the firm posted $0.83 EPS. Equities analysts predict that Steris Corp. will post $3.90 EPS for the current fiscal year.
In related news, VP Sudhir K. Pahwa sold 1,028 shares of Steris Corp. stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $70.13, for a total value of $72,093.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Adrian Vincent Coward sold 15,000 shares of Steris Corp. stock in a transaction that occurred on Wednesday, August 31st. The shares were sold at an average price of $69.00, for a total transaction of $1,035,000.00. The disclosure for this sale can be found here. 2.52% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in STE. Janus Capital Management LLC raised its position in Steris Corp. by 28.7% in the second quarter. Janus Capital Management LLC now owns 5,022,412 shares of the company’s stock worth $345,288,000 after buying an additional 1,120,438 shares in the last quarter. American Century Companies Inc. raised its position in Steris Corp. by 870.8% in the second quarter. American Century Companies Inc. now owns 1,208,491 shares of the company’s stock worth $83,084,000 after buying an additional 1,084,007 shares in the last quarter. Credit Suisse AG raised its position in Steris Corp. by 251.4% in the second quarter. Credit Suisse AG now owns 631,374 shares of the company’s stock worth $43,408,000 after buying an additional 451,699 shares in the last quarter. Champlain Investment Partners LLC raised its position in Steris Corp. by 92.6% in the second quarter. Champlain Investment Partners LLC now owns 898,485 shares of the company’s stock worth $61,771,000 after buying an additional 431,945 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA raised its position in Steris Corp. by 7.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 1,963,285 shares of the company’s stock worth $134,975,000 after buying an additional 128,956 shares in the last quarter. Institutional investors and hedge funds own 91.26% of the company’s stock.
STE has been the topic of a number of research reports. Zacks Investment Research cut shares of Steris Corp. from a “hold” rating to a “sell” rating in a report on Wednesday, September 14th. JMP Securities reaffirmed a “buy” rating on shares of Steris Corp. in a report on Friday, November 4th.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Receive News & Stock Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related stocks with our FREE daily email newsletter.